Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Vanilloid R1/TRPV1 Antibody Blocking Peptide
SDP

Catalog No. NB1001617E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB1001617E 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB1001617E Supplier Novus Biologicals™ Supplier No. NB1001617PEP
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide (synthetic) from rat TRPV1. Amino Acid Sequence: RASLDSEESESPPQENSC The Vanilloid R1/TRPV1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 7442
Species Rat
Content And Storage Store at -20°C.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB100-1617. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias Capsaicin receptor, Osm-9-like TRP channel 1, OTRPC1, transient receptor potential cation channel subfamily V member 1, transient receptor potential cation channel, subfamily V, member 1, transient receptor potential vanilloid 1 A, transient receptor potential vanilloid 1 b, TrpV1, Vanilloid receptor 1, vanilloid receptor subtype 1, VR1, VR1DKFZp434K0220
Gene Symbol TRPV1
Molecular Weight (g/mol) M.W. (theoretical): 1.96 kDa
Product Type Vanilloid R1/TRPV1
Quantity 0.1 mg
Regulatory Status RUO - research use only
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.